These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5637172)

  • 1. Methoxy derivatives of 5,5-diphenylhydantoin and 5-phenyl-5-benzylhydantoin.
    Novelli A; De Santis AM
    J Med Chem; 1968 Jan; 11(1):176-8. PubMed ID: 5637172
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticonvulsants. 5. Derivatives of 5-ethyl-5-phenylhydantoin and 5,5-diphenylhydantoin.
    Vida JA; O'Dea MH; Samour CM; Reinhard JF
    J Med Chem; 1975 Apr; 18(4):383-5. PubMed ID: 1121005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substitution in the hydantoin ring. VII. N-3-Propionic acid and its ethyl ester and N-3-(2-cyanoethyl) derivatives.
    Shaffer JW; Steinberg E; Krimsley V; Winstead WB
    J Med Chem; 1968 May; 11(3):462-6. PubMed ID: 5656482
    [No Abstract]   [Full Text] [Related]  

  • 4. Anticonvulsant activity of reaction products of 5,5-diphenylhydantoin with substituted methylene bromides.
    Usifoh CO
    Arch Pharm (Weinheim); 2001 Nov; 334(11):366-8. PubMed ID: 11822175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anticonvulsant activity of 3-ethoxycarbonyl-5,5-diphenylhydantoin (P-6127) in animals.
    Nakamura K; O'Hashi K; Nakatsuji K; Hirooka T; Fujimoto K; Ose S
    Arch Int Pharmacodyn Ther; 1965 Aug; 156(2):261-70. PubMed ID: 5868937
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanochemical preparation of hydantoins from amino esters: application to the synthesis of the antiepileptic drug phenytoin.
    Konnert L; Reneaud B; de Figueiredo RM; Campagne JM; Lamaty F; Martinez J; Colacino E
    J Org Chem; 2014 Nov; 79(21):10132-42. PubMed ID: 25279490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synthesis of benzylidene derivatives of 3-o, 3-m and 3-p-chlorophenylhydantoin and the study of their anticonvulsant action].
    Rydzik E; Szadowska A; Kamińska A
    Acta Pol Pharm; 1984; 41(4):459-64. PubMed ID: 6532133
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of substitution on anticonvulsant activity of some 5,5-diphenylhydantoin derivatives.
    Lange J; Lapszewicz J
    Acta Pol Pharm; 1990; 47(1-2):31-4. PubMed ID: 12959256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the cardiovascular effects of diphenylthiohydantoin and diphenylhydantoin.
    Gillis RA; Raines A
    Eur J Pharmacol; 1973 Jul; 23(1):13-8. PubMed ID: 4733768
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticonvulsants. 2. Acyloxymethyl and halomethyl derivatives of barbituric acid and diphenylhydantoin.
    Vida JA; Wilber WR; Reinhard JF
    J Med Chem; 1971 Mar; 14(3):187-9. PubMed ID: 5552206
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of continued administration of phenobarbital and diphenylhydantoin.
    HANZLIK PJ; LAQUEUR GL
    Stanford Med Bull; 1946 Feb; 4():21-32. PubMed ID: 21026028
    [No Abstract]   [Full Text] [Related]  

  • 12. [Favorable action of diphenylhydantoin on the resistance of the rat to drowning].
    GAYET-HALLION T; BERTRAND I
    C R Seances Soc Biol Fil; 1959; 153():757-9. PubMed ID: 13827004
    [No Abstract]   [Full Text] [Related]  

  • 13. Direct N
    Shintani Y; Kato K; Kawami M; Takano M; Kumamoto T
    Chem Pharm Bull (Tokyo); 2021; 69(4):407-410. PubMed ID: 33790085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synthesis of some 11C-labelled antiepileptic drugs with potential utility as radiopharmaceuticals: hydantoins and barbiturates.
    Roeda D; Westera G
    Int J Appl Radiat Isot; 1981 Nov; 32(11):843-5. PubMed ID: 7309275
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological properties of 3-aminoalkyl and amide derivatives of 5,5-diphenylhydantoin.
    Kieć-Kononowicz K; Stypuła E; Krupińska J; Cebo B
    Pol J Pharmacol Pharm; 1985; 37(5):693-9. PubMed ID: 3832013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of amide derivatives of 5,5-diphenylhydantoin as potential antiarrhythmic agents. I.
    Kieć-Kononowicz K; Zejc A; Krupińska J; Stypula E; Cebo B
    Farmaco Sci; 1987 Oct; 42(10):727-34. PubMed ID: 3436442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of diphenylhydantoin on electrolytes and radiosodium turnover in brain and other tissues of normal, hyponatremic and postictal rats.
    WOODBURY DM
    J Pharmacol Exp Ther; 1955 Sep; 115(1):74-95. PubMed ID: 13264059
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the thyroxine-diphenylhydantoin interaction: effect of 5,5'-diphenylhydantoin on the displacement of L-thyroxine from thyroxine-binding globulin (TBG).
    OPPENHEIMER JH; TAVERNETTI RR
    Endocrinology; 1962 Sep; 71():496-504. PubMed ID: 14482133
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the hypothermal properties of diphenylhydantoin].
    GAYET-HALLION T
    C R Seances Soc Biol Fil; 1959; 153():760-1. PubMed ID: 13827005
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the effect of diphenylhydantoin in painful conditions].
    STILLE G
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1960; 238():138-9. PubMed ID: 13834678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.